CJC-1295 + Ipamorelin (5mg/5mg) · Research brief
Tesamorelin Research Lab Setup Guide — Sourcing First
Short answer
Tesamorelin Research Lab Setup Guide Setting up a tesamorelin research program has less to do with benchtop equipment than with supply chain and documentation. Before the first vial arrives, you need a supplier who publishes third-party analysis you can verify yourself, a storage and inventory system suited to a long, temperature-sensitive peptide chain, labeling and record-keeping that keeps research-use-only material…
Tesamorelin Research Lab Setup Guide
Setting up a tesamorelin research program has less to do with benchtop equipment than with supply chain and documentation. Before the first vial arrives, you need a supplier who publishes third-party analysis you can verify yourself, a storage and inventory system suited to a long, temperature-sensitive peptide chain, labeling and record-keeping that keeps research-use-only material unambiguously separated from anything else on site, and wholesale terms stable enough to plan a catalog around. Real Peptides supplies tesamorelin to business buyers through its Wholesale Partner Program on exactly those terms — published COAs, 7-panel batch testing, and 99%+ HPLC purity. Everything below is the checklist that gets you from interest to a defensible sourcing decision.
Understanding what you are actually sourcing
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, built on a 44-amino-acid backbone with a modification at the N-terminal end. Research literature associates that modification with greater resistance to enzymatic degradation than the native sequence shows, which is a large part of why the compound appears in studies of growth hormone axis signaling at all. Published work generally examines GHRH-receptor agonism and downstream signaling, including IGF-1 pathways. Findings are research findings — studies indicate mechanisms of interest, and nothing about that body of work should be read as a promise of any outcome.
The practical consequence for a buyer is chain length. A 44-residue peptide is a fundamentally more fragile molecule than a short chain like a pentapeptide or a tripeptide. It has more sites where synthesis can go wrong, more opportunity for truncated or deletion sequences to survive purification, and more sensitivity to heat, moisture, and repeated temperature cycling once it leaves the manufacturing environment. Suppliers who can hold 99%+ purity on short sequences do not automatically hold it on long ones.
That is why identity confirmation matters as much as purity for this particular compound. A purity number alone tells you how much of the material in the vial is a single species. It does not tell you that the species is tesamorelin. Mass spectrometry closes that gap, and it is the first document a serious buyer should ask to see.
The documentation layer comes first
Before you evaluate price, evaluate paper. The industry's most common failure is not counterfeit material — it is material nobody can characterize, sold with a certificate that names no laboratory, no batch, and no date.
Ask for the following on every compound you intend to stock, and ask whether the documents are available before purchase or only after.
| Document | What it establishes | Warning sign |
|---|---|---|
| HPLC purity report | The proportion of the sample that is a single peptide species | No chromatogram image, only a stated percentage |
| Mass spectrometry | That the species present is the compound named on the label | Omitted entirely, or listed as 'conforms' with no data |
| Batch or lot identifier | That the report corresponds to the vials you receive | A generic COA reused across every shipment |
| Contaminant panel | Screening beyond purity — sterility, endotoxin, residual solvents and similar | Purity reported alone, with no safety panel |
| Independent lab attribution | That testing was not self-reported | No laboratory named, or an unnamed 'partner lab' |
| Public accessibility | That you and your own buyers can check the result | COAs sold separately, or released only on request |
Two practices deserve specific scrutiny. First, COAs that a supplier charges for, or releases only to account holders, function as a barrier to comparison rather than a service. Second, testing described as third-party without naming the third party cannot be verified by anyone. Neither practice is unusual in this market, and neither should be acceptable in a supplier you intend to build a catalog on.
Storage, handling, and inventory discipline
A research facility handling lyophilized peptides needs less specialized equipment than most first-time buyers expect, but it needs consistency. Freeze-dried peptide material is generally stored cold and protected from light and moisture, and the manufacturer's stated conditions for the specific lot govern. Build your inventory around temperature-controlled storage with a monitored log rather than an unmonitored unit, because an excursion you cannot document is an excursion you cannot account for later.
The operational side matters more than the hardware. Every lot that enters the facility should be logged against its batch number and its COA, so that any vial in inventory can be traced back to its analysis in one step. Research-use-only labeling should be applied and preserved on every unit, and research-use material should be physically separated from all other inventory. First-expiring, first-out rotation prevents slow-moving compounds from aging out on a shelf. For a business reselling into other research accounts, that log is also the documentation your own customers will eventually ask to see.
Cold-chain considerations extend to receiving. Establish who signs for shipments, what condition is checked at intake, and what happens to a shipment that arrives outside expected condition. A supplier's shipping practice is part of the product; ask how orders are packed and how transit temperature is managed before you order at volume.
What the milligram figure on a label does and does not tell you
This is the point where buyer questions most often cross a line, so it is worth stating plainly: Real Peptides does not provide dosing, preparation, or administration guidance for any compound in its catalog, because every compound is supplied for research use only and not for human consumption. That is a firm boundary, not a customer service gap.
What is useful to understand is the arithmetic that appears on documentation. A label reading 10mg states a mass — the quantity of peptide in the vial. Mass is not concentration. Concentration is mass divided by the volume of solvent it occupies, expressed as milligrams per milliliter, and it is a property of a prepared solution rather than of the vial as shipped. Understanding that distinction is what lets you compare two suppliers' listings on a like-for-like basis and what lets you evaluate whether a per-vial price is actually competitive on a per-milligram basis.
Beyond that framework, preparation decisions belong to the qualified researcher operating under their own institution's protocols. Any supplier volunteering preparation instructions with a research-use-only compound is telling you something about how carefully they read their own compliance obligations.
How wholesale pricing and order minimums actually work
Wholesale peptide pricing is almost always tiered by volume, and tiers are usually set per compound rather than across a whole order. The mechanics are consistent across the industry even though the numbers are not: unit cost falls as committed volume rises, minimum order quantities exist to keep fulfillment economics viable, and long-chain compounds like tesamorelin generally carry a different cost structure than short sequences because synthesis and purification are more demanding.
Margins vary widely by compound, volume, and how a reseller positions its catalog, and any supplier quoting you a specific margin figure before knowing your order profile is guessing. What you can evaluate concretely is pricing transparency. A tier structure you can see before applying lets you model your catalog. A structure disclosed only after a sales call, or quoted differently to different accounts, does not — and it tends to move against the buyer over time.
The questions worth asking any wholesale supplier: Are tier thresholds published? Do prices hold for a defined period or change without notice? Is there a minimum to maintain an account, separate from the minimum to place an order? Who absorbs the cost of a batch that fails your incoming inspection? Are COAs included at no cost with every lot?
Compliance questions to route through your attorney
This section is informational and is not legal advice. The regulatory landscape around research peptides involves federal frameworks, state professional licensing boards, and business licensing requirements that interact differently depending on what kind of entity you operate and what you do with the material. None of that resolves into a general rule that applies to everyone.
Bring these questions to qualified counsel before you commit to inventory. What business licenses does your entity need to purchase and hold research-use-only materials in your state? Does your state board impose requirements on your license type that touch this category, and in most states does the answer differ for a clinic, a wellness business, and a pure reseller? What resale documentation must you maintain, and for how long? How must research-use-only material be labeled and stored when it is resold to another business? What representations can and cannot appear in your own marketing?
A supplier can tell you what testing was performed and what the documentation shows. A supplier cannot tell you what your license permits. Any wholesaler that answers licensing questions with confident specifics about your state is offering you something it is not positioned to give.
What Real Peptides does differently
Real Peptides tests every batch to 99%+ HPLC purity and runs a 7-panel battery on each lot rather than reporting purity alone. The resulting certificates of analysis are published and publicly verifiable — a prospective partner can check the lab results directly, before opening an account and without asking a salesperson for permission. COAs are not a paid add-on and are not held back behind an account gate.
Fulfillment is handled domestically, with orders shipping in 5–7 days. Onboarding runs through a 3-step wholesale application: submit business details, complete verification, and receive tier pricing. Tesamorelin sits in the catalog alongside other compounds studied in growth hormone axis research, and the same testing and documentation standard applies to every item, not to a flagship subset.
The contrast worth drawing is not with any particular competitor but with a set of practices this market tolerates too easily: pricing that appears only after a sales conversation, certificates that cost extra, and testing attributed to a laboratory nobody names. Verifiable documentation removes the need to take a supplier's word for anything.
Bringing tesamorelin into your catalog
If your business is positioned to stock research-use-only compounds and you have your licensing questions settled with counsel, the next step is the Wholesale Partner Program application at Real Peptides. Review the published COAs first, confirm the documentation meets the standard your own buyers will hold you to, then apply for tier pricing on the compounds you intend to carry.
Research buyers evaluating growth hormone axis compounds can review Tesamorelin 10mg alongside related research compounds such as CJC-1295 No DAC 10mg and Ipamorelin 10mg, or browse the broader Growth Factor & Tissue Signaling Research and Popular Peptides collections to see how the same testing standard applies across the catalog.
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA